Javascript must be enabled to continue!
Repositioning randomly selected Drugs as Antidepressants by computational and Invivo methods
View through CrossRef
Abstract
Drug repositioning is also known as drug repurposing, drug refilling. Drug repositioning is one of the most preferred field in current research. The drugs with different adverse effect and the drugs which are shelved can be used for the treatment of other diseases. Thus it helps in finding new therapeutic index for already existing drugs. The main advantage of this drug reposioning is it decreases the investment in drug discovery and optimization, and all the pharmacokinetics studies will be readily available as their profiles are already established. In recent times one of the most useful strategies for repositioning the drug of the therapeutic activity towards other new target is done by computational screening. The deeper knowledge about pathogenesis of depression helps us to develop or discover the new drug moieties through drug repositioning to treat the disease condition of depression. In this study we have selected randomly some available drugs and repurposed them as potent anti depressant agents using Insilico and Invivo studies.
Title: Repositioning randomly selected Drugs as Antidepressants by computational and Invivo methods
Description:
Abstract
Drug repositioning is also known as drug repurposing, drug refilling.
Drug repositioning is one of the most preferred field in current research.
The drugs with different adverse effect and the drugs which are shelved can be used for the treatment of other diseases.
Thus it helps in finding new therapeutic index for already existing drugs.
The main advantage of this drug reposioning is it decreases the investment in drug discovery and optimization, and all the pharmacokinetics studies will be readily available as their profiles are already established.
In recent times one of the most useful strategies for repositioning the drug of the therapeutic activity towards other new target is done by computational screening.
The deeper knowledge about pathogenesis of depression helps us to develop or discover the new drug moieties through drug repositioning to treat the disease condition of depression.
In this study we have selected randomly some available drugs and repurposed them as potent anti depressant agents using Insilico and Invivo studies.
Related Results
Hyoid bone position and upper airway patency: A computational finite element modeling study
Hyoid bone position and upper airway patency: A computational finite element modeling study
ABSTRACT
Background and Objectives
The hyoid bone’s inferior baseline position in obstructive sleep apnea (OSA) has led to surg...
IMPACT OF PROLONGED USE OF ANTIDEPRESSANTS ON NEUROPLASTICITY
IMPACT OF PROLONGED USE OF ANTIDEPRESSANTS ON NEUROPLASTICITY
Antidepressants are widely used in the treatment of depressive and anxiety disorders and are essential for the management of these conditions. However, the impact of prolonged use ...
Antidepressants Drugs and Addiction Treatment: A development view and a technological patent landscape of drugs and compositions
Antidepressants Drugs and Addiction Treatment: A development view and a technological patent landscape of drugs and compositions
Background: According to the World Health Organization, about 76-85% of subjects in low- and middle-income countries suffer with a mental disorder. From them the most prevalent are...
Effectiveness of antidepressants in bipolar depression
Effectiveness of antidepressants in bipolar depression
IntroductionPrescribing antidepressants in the treatment of bipolar depression remains highly controversial due to the inconsistency between routine clinical practice and the resul...
Antidepressants Enhance Host-Resistance in the Body
Antidepressants Enhance Host-Resistance in the Body
A review of scientific literature indicates that the use of antidepressants can be generalized to all forms of stress and inflammation as an adjunctive therapy that enhances host r...
Why antidepressants are not antidepressants: STEP‐BD, STAR*D, and the return of neurotic depression
Why antidepressants are not antidepressants: STEP‐BD, STAR*D, and the return of neurotic depression
The widely held clinical view of ‘antidepressants’ as highly effective and specific for the treatment of all types of depressive disorders is exaggerated. This sobering conclusion ...
RepCOOL: computational drug repositioning via integrating heterogeneous biological networks
RepCOOL: computational drug repositioning via integrating heterogeneous biological networks
Abstract
Background
It often takes more than 10 years and costs more than 1 billion dollars to develop a new drug for a p...
Individual response to antidepressants for depression in adults – a meta-analysis and simulation study
Individual response to antidepressants for depression in adults – a meta-analysis and simulation study
Background The observation that some patients appear to respond better to antidepressants for depression than others encourages the assumption that the effect of antidepressants di...

